Emyria Ltd (ASX:EMD) says it has achieved key execution milestones ahead of launching its first Empax mental health clinic in Victoria, with patient treatments on track to begin in the second quarter of calendar 2026.
The company said progress across workforce, operational readiness and funding pathways had reduced execution risk and supported a clear pathway to near-term revenue generation.
Workforce build supports ramp-up
Emyria has contracted and trained 31 Victorian therapists and four psychiatrists, with two more psychiatrists scheduled for training in Q2 2026.
The growing pool of authorised prescribers and therapists is expected to support scalable patient throughput and a smoother ramp-up following launch.
Operational steps advance revenue readiness
Key operational milestones have also been completed, including securing medication supply and finalising an agreement with site partner Avive Health, allowing clinic fit-out works to begin.
The company is also progressing pharmacy agreements and clinical governance integration, which it said further de-risks the rollout.
Funded pathways underpin demand
Emyria highlighted dual reimbursement channels as a key driver of early utilisation, with Medibank funding eligible patients and the Department of Veterans’ Affairs supporting treatment for qualifying veterans.
These pathways are expected to reduce reliance on self-funded patients and provide stronger revenue visibility from launch.
“We are pleased to see strong execution across all workstreams as we approach the launch of our first Victorian Empax clinic,” executive chairman Greg Hutchinson said. “With funded patient pathways in place and operational readiness advancing, we believe this clinic will play a key role in driving growth and expanding access to reimbursable, evidence-based mental health treatments.”